The Effect of Stress Inoculation Training (SIT) on Depression and Quality of Life in Multiple Sclerosis (MS) Patients with Control of Duration of Disease in Esfahan City

Document Type : Original Article


1 Associate Professor of Psychology.Department of Psychology, Shahid Chamran University of Ahvaz,Iran.

2 Professor of Psychology,Department of Psychology, Shahid Chamran University of Ahvaz,Iran.

3 Lecturer of Psychology. Department of Psychology, Shahid Chamran University of Ahvaz,Iran.


Background and Objective: The aim of this research was to study the effect of stress inoculation training (SIT) on depression and quality of life in Ms Patients.
Subjects and Methods: The research method was experimental with pre-post test and control group. The original samples consisted of 83 Patients who were selected from Isfahan MS association. They were matched from age, sex, educational status, duration of MS disease, depression and other criteria considered in this research. They were randomly divided into two groups as experimental and control. The instruments were BDI and MSIS-29 Scales. We used MANOVA to analyze the data.
Results: The results indicated that there was a significant difference between two groups (p<0.001). The rate of depression decreased and the quality of life increased significantly in experimental group in comparison with the pre test and control group.
Conclusion: Stress inoculation training (SIT) decreased the depression and increased the quality of life in MS Patients. Therefore, it is recommended to use this method for MS Patients.


1-Etemadifar M, Chitsaz A. Multiple Sclerosis MS. Esfahan: Esfahan University of Medical Sciences publication; 2005. p. 120-42.
2-Bardley W, Daroff R, Fenichel G, Marsden C. MS. Neurology in clinical practice 1996;1308-35.
3-Nafissi S, Ayatollahi P, Eshraghian MR, Kaviani Hl, Tarazi A. Determinants of quality of life in Iranian with Multiple Sclerosis. Journal of the Neurological Science 2005; 238:S239.
4-Visschedijk MA, Collette EH, Polman CH, Pfennings LE, Van Der Ploeg HM. Development of a cognitive behavioral group intervention programme for patients with Multiple Sclerosis an exploratory study. Psychol Rep 2004; 95:735-46.
5-Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M. Efficacy of Stress-Inoculation Training in coping with Multiple Sclerosis. J Consult Clin Psychol 1987; 55:912-22.
6-Hoseinzadeh Z. Study the efficacy of Stress Inoculation Training (SIT) on reduction of depression and anxiety in MS patients [dissertatin]. Tehran: Islamic Free University, Research Science unit; 2007. [Persian]
7-Mokhtary S. Study the effects of cognitive behavioral group intervention on depression for patients with Multiple Sclerosis (MS) [dissertation]. Esfahan: Esfahan University; 2005. [Persian]
8-Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, et al. Health-related quality of life and depression in an Italian sample of Multiple Sclerosis patients. J Neurol Sci 2003; 211:55-62.
9-Mohr DC, Hart SL, Goldberg A. Effects of treatment for depression on fatigue in multiple zclerosis. Psychosom Med 2003; 65:542-7.
10-Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, et al. Telephon-administered psychotherapy for depression. Arch Gen Psychiatry 2005; 62:1007-14.
11-O’Hara L, Cadbury H, De SL, Ide L. Evaluation of the effectiveness of professionally guided self-care for people with Multiple Sclerosis living in the community: A randomized controlled trial. Clin Rehabil 2002; 16:119-28.
12-Hazrati M, Zahmatkeshan N, DejBakhsh T, Nik Seresht A, Zeyghami B. The effect of rehabilitation on the quality of life in Multiple Sclerosis patients. Armaghane-Danesh, Journal of Yasuj University of Medical
      Sciences 2005; 39:53-64 [Persian].
13-Mohamady N. Study the efficacy of cognitive behavioral group intervention on depression for patients with Multiple Sclerosis. (MS) [dissertation]. Esfehan: Esfehan University; 2005. [Persian]
14- Visschedijk MA , Mohr DC, Foley FW. Cognitive behavioral group intervention programme for patients with Multiple Sclerosis. Psychol Rep 2009; 85: 841- 59.
15-Azkhosh M. Using clinical and psychological tests. Tehran: Ravan publication; 2000.
16-Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure. Brain 2001; 124: 962-73.
17-Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thampson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol, Neurosurg Psychiatry 2002; 73:701-4.
18-Ayatollahi P, Nafissi S, Eshraghian MR, Tarazi A. Cross-Cultural adaptation of the Multiple Sclerosis Impact Scale (MSIS-29) for Iranian MS patients, evaluation of reliability and validity. Tehran University Medical Journal 2006; 64:62-8. [Persian]
19-Meichenbaum D. Stress Inoculation Training. New York: Pergamon; 1985.
20-Larcombe NA, Wilson PH. An evaluation of cognitive-behaviour therapy for depression in patients with Multiple Sclerosis. Br J Pyschiatry 1984; 145:366-71.
21-Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trail of an energy conservation course for persons with Multiple Sclerosis. Mult Scler 2005; 11:592-601.
22-Maguire BL. The effects of imagery on attitudes and moods in Multiple Sclerosis patients. Altern Ther Health Med 1996; 2:75-9.
23-Tesar N, Baumhackl U, Kopp M, Gunther V. Effects of psychological group therapy in patients with Multiple Sclerosis. Acta Neurol Scand 2003;107:394-9.